Lyell Immunopharma
Venture Capital
Lyell is a clinical-stage company advancing next-generation CAR T-cell product candidates for patients with cancer.
1+ investments · 1 portfolio companies
Biotech
- Website
- lyell.com
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- Sep 2020
Overview
Lyell Immunopharma is a Venture Capital firm. It has made 1 investment, including Sonoma Biotherapeutics. Focus areas include Biotech.
Portfolio1
Co-investors7
Sign up to view co-investors
7 co-investors across 7 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×5 · Corporate VC ×2 · 3 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/lyell-immunopharma"><img src="https://indexed.vc/api/badge/investor/lyell-immunopharma" alt="Lyell Immunopharma on Indexed.vc" width="260" height="76" /></a>